Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,182Revenue $M757Net Margin (%)5.2Altman Z-Score0.9
Enterprise Value $M2,468EPS $0.2Operating Margin %7.3Piotroski F-Score5
P/E(ttm)65.0Beneish M-Score-1.1Pre-tax Margin (%)-17.5Higher ROA y-yY
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow13.1y-y EBITDA Growth Rate %284ROA % (ttm)1.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)3.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M160ROIC % (ttm)-4.7Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPJulian Robertson 2015-12-31 Buy 2.3%$13.12 - $22.58
($19.53)
$ 13.73-30%New holding823,577
HZNPJoel Greenblatt 2015-12-31 Buy 0.49%$13.12 - $22.58
($19.53)
$ 13.73-30%New holding2,075,017
HZNPKen Heebner 2015-12-31 Buy 0.15%$13.12 - $22.58
($19.53)
$ 13.73-30%New holding205,000
HZNPRon Baron 2015-12-31 Sold Out $13.12 - $22.58
($19.53)
$ 13.73-30%Sold Out0
HZNPSteve Mandel 2015-09-30 Add1.03%$16.81 - $38.45
($31.59)
$ 13.73-57%Add 386.77%15,600,988
HZNPRon Baron 2015-09-30 Buy $16.81 - $38.45
($31.59)
$ 13.73-57%New holding31,999
HZNPSteve Mandel 2015-06-30 Buy 0.42%$25.6 - $34.74
($30.45)
$ 13.73-55%New holding3,204,972
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 13.73-25%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 13.7310%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 13.7319%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 13.73-4%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-02-26Sell4,100$20-27.05view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-12-10Sell4,456$20-27.05view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-09-21Sell7,750$31.78-54.09view
Watkins ThomasDirector 2015-08-19Buy10,000$31.32-53.42view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-58.96view
Himawan JeffDirector 2015-03-13Sell554,564$22.44-34.98view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.85-33.23view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.0521.08view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.0521.08view
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.0521.08view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Julian Robertson Buys 8 New Stakes in 4th Quarter Mar 09 2016 
Sheets Smith Wealth Management Buys Companies With no Debts Sep 01 2015 
Horizon Pharma Leads Stock Returns in Health Care Industry Aug 24 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
Biotech Effectiveness: Horizon Pharma, Zafgen, XOMA Corp Mar 09 2015 

More From Other Websites
Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R)... May 05 2016
8:38 am Horizon Pharma completes target enrollment of its Phase 3 study evaluating ACTIMMUNE... May 05 2016
Horizon Pharma plc Completes Target Enrollment of 90 Patients for Phase 3 Trial of ACTIMMUNE(R)... May 05 2016
Sohn Investment Conference 2016 – Full Wrap Up May 04 2016
HORIZON PHARMA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... May 04 2016
What's in Store for Horizon (HZNP) This Earnings Season? May 04 2016
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Three Additional... May 04 2016
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Three Additional... May 04 2016
GPM Reminds Investors of the May 9 Deadline in the Class Action Lawsuit Against Horizon Pharma plc... May 03 2016
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... May 03 2016
Horizon Pharma plc to Present at Two Investor Conferences in May May 03 2016
Horizon Pharma plc to Present at Two Investor Conferences in May May 03 2016
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving... May 02 2016
MAY 9, 2016 DEADLINE ALERT: Brower Piven Reminds Investors Who Have Losses in Excess of $100,000... May 02 2016
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of... May 02 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... Apr 29 2016
INVESTOR ALERT: Rosen Law Firm Reminds Horizon Pharma plc Investors of Important May 9 Deadline in... Apr 28 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Horizon Pharma plc of Class Action... Apr 28 2016
DEADLINE ALERT: Hagens Berman Reminds Horizon Pharma (NASDAQ: HZNP) Investors of May 9, 2016 Lead... Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)